Evidence map›Paper›PMID 41200890›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

3D Membrane Microstructures for Increased Efficiency in Blood-Gas Transfer.

Kai P Barbian, F Neuhaus, L T Hirschwald, J Linkhorst, M Wessling, B Wiegmann, J M Focke, U Steinseifer, M Neidlin, S V Jansen

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. 3D Membrane Microstructures for Increased Efficiency in Blood-Gas Transfer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Tailored 3D Lattice Microstructures for Enhanced Functionality in Blood-Gas Exchange.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kai P BarbianDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.ORCID https://orcid.org/0009-0009-2749-3777
F NeuhausChemical Process Engineering (AVT.CVT), RWTH Aachen University, Forckenbeckstr. 51, 52074, Aachen, Germany.
L T HirschwaldChemical Process Engineering (AVT.CVT), RWTH Aachen University, Forckenbeckstr. 51, 52074, Aachen, Germany.
J LinkhorstChemical Process Engineering (AVT.CVT), RWTH Aachen University, Forckenbeckstr. 51, 52074, Aachen, Germany.
M WesslingChemical Process Engineering (AVT.CVT), RWTH Aachen University, Forckenbeckstr. 51, 52074, Aachen, Germany.
B WiegmannDepartment for Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
J M FockeDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.
U SteinseiferDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.
M NeidlinDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.
S V JansenDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.

Funding

Deutsche Forschungsgemeinschaft (DFG) 347368182Medizinische Fakultät, RWTH Aachen University, START 116/23
6 · The paper itself

Abstract

Treating severe lung diseases with extracorporeal membrane oxygenation (ECMO) is often accompanied by serious complications, restricting applicability and adversely affecting outcomes. Membrane oxygenators, based on hollow fiber membranes (HFM), are a central ECMO component. Here, current designs are reaching their limits regarding hemocompatibility and gas transfer efficiency. Three-dimensional structures, based on triply periodic minimal surfaces, can provide superior hemodynamics. However, previous 3D membrane structures don't provide the required channel scale and gas transfer performance. In this study, we have fabricated 3D microstructures and tested them in vitro against state-of-the-art HFM. The 3D structure provided gas transfer coefficients within 50 and 45% of the HFM's value for oxygen and carbon dioxide, respectively. Specific pressure drops within the 3D structure are more than ten times lower than in the HFM. Combining these aspects, the 3D structure showed 51and 33% higher mass-transfer efficiency for oxygen and carbon dioxide, respectively. By further reducing channel scale, the 3D structure can help to miniaturize oxygenators while maintaining efficiency. Thereby, the invasiveness of ECMO could be reduced to improve outcomes. Our approach for the design and manufacturing of 3D membrane microstructures can be transferred to other mass-transfer applications like bioreactors or microfluidic cell culture.

Indexed as

Extracorporeal Membrane OxygenationMembranes, ArtificialOxygenators, MembraneCarbon DioxideEquipment DesignHumansOxygenCarbon DioxideMembranes, ArtificialOxygenblood contactorsECMOmass transfermembrane oxygenatorsmicrostructuresTPMS

Identifiers

PMID41200890
PMCPMC12713010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.